Brianne Allen, MA - CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1683 Elm Brook Trail, Dayton, OH 45458 Phone: 937-638-5135 |
Catherine Lorraine Zahora, M.ED, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 S Keowee St, Dayton, OH 45402 Phone: 859-473-3026 |
Kari Parks Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4401 Free Pike, Dayton, OH 45416 Phone: 937-542-4229 |
Ms. Audrey Elizabeth Walstrom, M.A., D.M.A. Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1222 S Patterson Blvd, Dayton, OH 45402 Phone: 937-496-2622 |
Mrs. Linda Ann Springman, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 627 W Nottingham Rd, Dayton, OH 45405 Phone: 937-276-9956 |
Alyssa Louise Miller, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7300 Mcewen Rd, Dayton, OH 45459 Phone: 937-433-3441 |
Emily Ankeney Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5790 Denlinger Rd, Dayton, OH 45426 Phone: 937-837-5581 |
Alicia Riley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3705 Lori Sue Ave, Dayton, OH 45406 Phone: 937-542-4390 |
Bonnie Ann Sekely, M.A.,C.C.C.,SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Wyoming St, Dayton, OH 45409 Phone: 937-208-8000 |
John Michael Pearson, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4710 Old Troy Pike, Dayton, OH 45424 Phone: 937-233-1230 |
Victoria Kiefaber Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 S Ludlow St, Dayton, OH 45402 Phone: 937-542-4569 |
Angela Campanelli Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1222 S Patterson Blvd, Dayton, OH 45402 Phone: 937-496-2600 Fax: 937-496-2614 |
Ms. Denise K Ashworth, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4100 W 3rd St, Dayton, OH 45428 Phone: 937-262-2148 |
Amy Barnett Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4020 Bradwood Dr, Dayton, OH 45405 Phone: 937-542-5723 |
Eileen June Barry Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 S Ludlow St, Dayton, OH 45402 Phone: 937-542-3409 |
Alexandra Cornejo Haijsman, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Childrens Plz, Dayton, OH 45404 Phone: 937-641-3000 |
Marissa Dibenedetto Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 S Ludlow St, Dayton, OH 45402 Phone: 937-542-3052 |
Julie Fronista Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6951 Springboro Pike, Dayton, OH 45449 Phone: 937-434-9191 |
Timothy Clyde Earls, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 407 Ambrose Ct, Dayton, OH 45410 Phone: 937-542-5680 |
Jennifer Heckler, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Harbert Dr, Suite B, Dayton, OH 45440 Phone: 937-427-1919 Fax: 937-427-1949 |
News Archive
Patients with irreversible intestinal failure have few options for treatment.
Data presented today at the American Society of Hypertension, Inc.'s 25th Annual Scientific Meeting and Exposition demonstrate a link between short cycles of sleep, stroke and silent cerebral infarct, or "silent strokes," in elderly hypertensive patients.
In Virginia, one member of the panel charged with exploring the idea of expanding the health insurance program for people with low incomes said any broadening of the program was unlikely to happen in the near future. In Mississippi, many low-income people will soon realize they won't be eligible for Medicaid because the state opted against the expansion.
Bellicum Pharmaceuticals, Inc. today announced dosing of the first patient in a Phase I/II clinical trial of BP-GMAX-CD1, a novel pharmacologically regulated dendritic cell vaccine for the treatment of prostate cancer. The disease-specific trial is being conducted under a Bellicum Investigational New Drug application allowed by the FDA in 2008. The company anticipates reporting initial results of the study in 2010.
› Verified 1 days ago